Design considerations in building in silico equivalents of common experimental influenza virus assays

References

• Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron AJ. Time lines of infection and disease in human influenza: A review of volunteer challenge studies. Am J Epidemiol. 2008; 167:775–785.
   PubMed Web of Science ®Google Scholar
• Baz M, Abed Y, Simon P, Hamelin M, Boivin G. Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses. J Infect Dis. 2010; 201:740–745.
   PubMedGoogle Scholar
• Yen HL, Herlocher LM, Hoffmann E, Matrosovich MN, Monto AS, Webster RG, Govorkova EA. Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility. Antimicrob Agents Chemother. 2005; 49:4075–4084.
   PubMed Web of Science ®Google Scholar
• Matrosovich MN, Matrosovich T, Carr J, Roberts NA, Klenk HD. Overexpression of the α-2,6-Sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. J Virol. 2003; 77:8418–8425.
   PubMed Web of Science ®Google Scholar
• Hatakeyama S, Sakai-Tagawa Y, Kiso M, Goto H, Kawakami C, Mitamura K, Sugaya N, Suzuki Y, Kawaoka Y. Enhanced expression of an α-2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor. J Clin Microbiol. 2005; 43:4139–4146.
   Google Scholar
• Tisdale M. Monitoring of viral susceptibility: New challenges with the development of influenza NA inhibitors. Rev Med Virol. 2000; 10:45–55.
   PubMed Web of Science ®Google Scholar
• Beauchemin C, McSharry J, Drusano G, Nguyen J, Went G, Ribeiro R, Perelson A. Modeling amantadine treatment of influenza A virus in vitro. J Theor Biol. 2008; 254:439–451.
   PubMed Web of Science ®Google Scholar
• Dahari H, Ribeiro R, Rice C, Perelson A. Mathematical modeling of subgenomic hepatitis C virus replication in Huh-7 cells. J Virol. 2007; 81:750–760.
   Google Scholar
• Möhler L, Flockerzi D, Sann H, Reichl U. Mathematical model of influenza A virus production in large-scale microcarrier culture. Biotechnol Bioeng. 2005; 90:46–58.
   PubMed Web of Science ®Google Scholar
• Baccam P, Beauchemin C, Macken C, Hayden F, Perelson A. Kinetics of influenza A virus infection in humans. J Virol. 2006; 80:7590–7599.
   PubMed Web of Science ®Google Scholar
• Kermack W, McKendrick A. Contributions to the mathematical theory of epidemics, Part I. Proc R Soc Lond Ser A. 1927; 115:700–721.
   Google Scholar
• Anderson R, May R. Population biology of infectious diseases: Part I. Nature. 1979; 280:361–367.
   PubMed Web of Science ®Google Scholar
• Anderson R, May R. Population biology of infectious diseases: Part II. Nature. 1979; 280:455–461.
   Google Scholar
• Nowak M, May R, Anderson R. The evolutionary dynamics of HIV-1 quasispecies and the development of immunodeficiency disease. AIDS. 1990; 4:1095–1103.
   Google Scholar
• Perelson A, Kirschner D, de Boer R. Dynamics of HIV infection of CD4+ T cells. Math Biosci. 1993; 114:81–125.
   PubMed Web of Science ®Google Scholar
• Nowak M, Bonhoeffer S, Hill A, Bohme R, Thomas H, McDade H. Viral dynamics in hepatitis B infection. Proc Natl Acad Sci USA. 1996; 93:4398–4404.
   PubMed Web of Science ®Google Scholar
• Hethcote H, Tudor D. Integral equation models for endemic infectious diseases. J Math Biol. 1980; 9:37–47.
   Web of Science ®Google Scholar
• Handel A, Longini I, Antia R. Neuraminidase inhibitor resistance in influenza: Assessing the danger of its generation and spread. PLoS Comput Biol. 2007; 3:2456–2464.
   Web of Science ®Google Scholar
• Handel A, Longini I, Antia R. Towards a quantitative understanding of the within-host dynamics of influenza A infections. J R Soc Interface. 2010; 7:35–47.
   Web of Science ®Google Scholar
• Dulbecco R, Vogt M. Plaque formation and isolation of pure lines with poliomyelitis viruses. J Exp Med. 1954; 99:167–182.
   PubMed Web of Science ®Google Scholar
• Hahon N, Booth J, Eckert H. Cell attachment and penetration by influenza virus. Infect Immun. 1973; 7:341–351.
   PubMed Web of Science ®Google Scholar
• Smith A, Adler F, Perelson A. An accurate two-phase approximate solution to an acute viral infection model. J Math Biol. 2010; 60:711–726.
   Google Scholar
• Hale B, Knebel A, Botting C, Galloway C, Precious B, Jackson D, Elliott R, Randall R. CDK/ERK-mediated phosphorylation of the human influenza A virus NS1 protein at threonine-215. Virology. 2009; 383:6–11.
   Google Scholar
• Beauchemin C, Forrest S, Koster F. Modeling influenza viral dynamics in tissue. Lect Notes Comput Sci. 2006; 4163:23.
   Google Scholar
• Holder BP, Simon P, Liao LE, Abed Y, Bouhy X, Beauchemin CAA, Boivin G. Assessing fitness of an oseltamivir-resistant seasonal A/H1N1 influenza strain using a mathematical model 2010, Submitted.
   Google Scholar
• Lloyd AL. Dependence of viral parameter estimates on the assumed viral life cycle: Limitations of studies of viral load data. Proc R Soc Lond B Biol Sci. 2001; 268:847–854.
   PubMed Web of Science ®Google Scholar
• Mittler JE, Sulzer B, Neumann AU, Perelson AS. Influence of delayed viral production on viral dynamics in HIV-1 infected patients. Math Biosci. 1998; 152:143–163.
   Google Scholar
• Grossman Z, Feinberg M, Kuznetsov V, Dimitrov D, Paul W. HIV infection: How effective is drug combination treatment?. Immunol Today. 1998; 19:528–532.
   Google Scholar
• Banks H, Bortz DM, Holte SE. Incorporation of variability into the modeling of viral delays in HIV infection dynamics. Math Biosci. 2003; 183:63–91.
   Google Scholar
• Wearing HJ, Rohani P, Keeling MJ. Appropriate models for the management of infectious diseases. PLoS Med. 2005; 2:621–627.
   Web of Science ®Google Scholar
• Feng Z, Xu D, Zhao H. Epidemiological models with non-exponentially distributed disease stages and applications to disease control. Bull Math Biol. 2007; 69:1511–1536.
   PubMed Web of Science ®Google Scholar
• Beauchemin C. Probing the effects of the well-mixed assumption on viral infection dynamics. J Theor Biol. 2006; 242:464–477.
   Google Scholar
• Monto A, McKimm-Breschkin J, Macken C, Hampson A, Hay A, Klimov A, Tashiro M, Webster R, Aymard M, Hayden F, Zambon M. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother. 2006; 50:2395–2402.
   PubMed Web of Science ®Google Scholar
• Matrosovich M, Matrosovich T, Garten W, Klenk H. New low-viscosity overlay medium for viral plaque assays. Virol J. 2006; 3:63.
   PubMed Web of Science ®Google Scholar
• Beauchemin CA. MASyV: A Multi-Agent System Visualization package. Free open-source GNU GPL software available online on SourceForge.net 2007.
   Google Scholar